Galera Therapeutics Inc.
13F holders, Q2 2024 (June 30)1holders −35
0new positions
36sold out
$0.14avg. 13F price*
At the end of Q2 2024, 1 institutions reported holding Galera Therapeutics Inc. in their 13F filings, down 35 from Q1 2024. 0 opened new positions and 36 sold out. The largest holder was XTX Topco Ltd ($7K).
- Company
- Galera Therapeutics Inc.
- CUSIP
- 36338D108
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 36 | $1.4M |
All 13F filers, Q1 2024 → Q2 2024: 26,867 shares bought and 9,756,699 shares sold, net −9,729,832 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| XTX Topco Ltd | 0.00% | Add +106.4% | 52,113 | $7K |
"% of holder's portfolio" is GALERA THERAPEUTICS INC's weight in each manager's 13F, not the share of Galera Therapeutics Inc. the manager owns.